NuMask Versus Traditional Mask Ventilation During Routine Care

May 6, 2017 updated by: Derek Sakata

A Comparison of Controlled Ventilation With the NuMask vs. Traditional Mask Ventilation.

The direct objective of this study is to determine whether an experienced provider can more adequately and/or easily ventilate an anesthetized patient with the NuMask device as compared to traditional bag-valve-mask ventilation. These are approved masks, being used in the patients routine care. The researchers believe that mean tidal volumes obtained by experienced providers when manually ventilating anesthetized patients with the NuMask device will be larger than when using the traditional bag-valve-mask.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

44

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients selected will be undergoing elective surgery at the University of Utah

Description

Inclusion Criteria:

  • 44 adults total
  • ASA status I-III
  • aged 18-64
  • elective surgery at the University of Utah under general anesthesia
  • Bearded, BMI >35 or edentulous

Exclusion Criteria:

  • ASA IV or higher
  • Oropharyngeal or facial pathology
  • Risk of aspiration (defined by need for rapid sequence intubation, uncontrolled gastroesophageal reflux disease)
  • Known and/or documented difficulty placing an endotracheal tube in the past
  • Limited neck extension or flexion
  • Personal or familial history of malignant hyperthermia
  • Known or predicted severe respiratory disease or compromise
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
NuMask
Pt's randomized to Numask first will be ventilated for 10 breaths with the NuMask device first, followed by 10 breaths with the traditional face mask
The NuMask is a relatively new mask ventilation device that has been registered with the FDA and used in the United States since 2006.
A traditional air inflated facemark used to ventilate patients
Traditional mask
patients randomized to traditional mask first will receive 10 breaths by traditional mask, followed by 10 breaths with NuMask
The NuMask is a relatively new mask ventilation device that has been registered with the FDA and used in the United States since 2006.
A traditional air inflated facemark used to ventilate patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tidal Volume comparison
Time Frame: 2 minutes (one minute for NuMask, one minute for traditional mask)
Tidal volumes delivered between the two devices will be compared
2 minutes (one minute for NuMask, one minute for traditional mask)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of use
Time Frame: 2 minutes
Provider will rate each device for ease of use on a 1-5 scale with 1 being easy and 5 being difficult.
2 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Derek Sakata, MD, University of Utah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (ACTUAL)

January 1, 2014

Study Completion (ACTUAL)

January 1, 2014

Study Registration Dates

First Submitted

June 17, 2016

First Submitted That Met QC Criteria

July 6, 2016

First Posted (ESTIMATE)

July 11, 2016

Study Record Updates

Last Update Posted (ACTUAL)

May 9, 2017

Last Update Submitted That Met QC Criteria

May 6, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IRB_00042299

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Apnea

Clinical Trials on NuMask

Subscribe